Lipoprotein metabolism and cholesterol balance

The Liver: Biology and Pathobiology

Volumn , Issue , 2009, Pages 271-285

  Cohen, David E ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84889854315     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470747919.ch19     Document Type: Chapter

References (85)

1. Small, D.M. (1986) The Physical Chemistry of Lipids. From Alkanes to Phospholipids, Plenum Press, New York.
2. Jonas, A. (2002) Lipoprotein structure, in Biochemistry of Lipids, Lipoproteins and Membranes, (eds D.E. Vance and J.E. Vance), Elsevier, Amsterdam, pp. 483-84.
3. Hussain, M.M., Shi, J. and Dreizen, P. (2003) Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res, 44, 22-32.
4. Anant, S. and Davidson, N.O. (2001) Molecular mechanisms of apolipoprotein B mRNA editing. Curr Opin Lipidol, 12, 159-65.
5. Fisher, E.A. and Ginsberg, H.N. (2002) Complexity in the secretory pathway: the assembly and secretion of apolipoprotein B-containing lipoproteins. J Biol Chem, 277, 17377-80.
6. Wang, D.Q. (2007) Regulation of intestinal cholesterol absorption. Annu Rev Physiol, 69, 221-48.
7. Carey, M.C., Small, D.M. and Bliss, C.M. (1983) Lipid digestion and absorption. Annu Rev Physiol, 45, 651-77.
8. Wang, D.Q. and Cohen, D.E. (2008) Regulation and absorption of cholesterol and other sterols and excretion, in Clinical Lipidology: A Companion to Braunwald’s Heart Disease (ed. C.M. Ballantyne), Elsevier, Amsterdam, pp. 26-44.
9. Hui, D.Y., Labonte, E.D. and Howles, P.N. (2008) Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption. Am J Physiol Gastrointest Liver Physiol, 294, G839-43.
10. Altmann, S.W., Davis, H.R. Jr., Zhu, L.J., Yao, X., Hoos, L.M., Tetzloff, G., Iyer, S.P., Maguire, M., Golovko, A., Zeng, M., Wang, L., Murgolo, N. and Graziano, M.P. (2004) Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption. Science, 303, 1201-4.
11. Yu, L., Li-Hawkins, J., Hammer, R.E., Berge, K.E., Horton, J.D., Cohen, J.C. and Hobbs, H.H. (2002) Overexpression of ABCG5 and ABCG8 promotes biliary cholesterol secretion and reduces fractional absorption of dietary cholesterol. J Clin Invest, 110, 671-80.
12. Joyce, C., Skinner, K., Anderson, R.A. and Rudel, L.L. (1999) Acyl-coenzyme a: cholesteryl acyltransferase 2. Curr Opin Lipidol, 10, 89-95.
13. Lin, J., Yang, R., Tarr, P.T., Wu, P.H., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., Newgard, C.B. and Spiegelman, B.M. (2005) Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell, 120, 261-73.
14. Iizuka, K. and Horikawa, Y. (2008) ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome. Endocr J, 55, 617-24.
15. Lee, A.H., Scapa, E.F., Cohen, D.E. and Glimcher, L.H. (2008) Regulation of hepatic lipogenesis by the transcription factor XBP1. Science, 320, 1492-96.
16. Pan, M., Cederbaum, A.I., Zhang, Y.L., Ginsberg, H.N., Williams, K.J. and Fisher, E.A. (2004) Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production. J Clin Invest, 113, 1277-87.
17. Brodsky, J.L. and Fisher, E.A. (2008) The many intersecting pathways underlying apolipoprotein B secretion and degradation. Trends Endocrinol Metab, 19, 254-59.
18. Shachter, N.S. (2001) Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol, 12, 297-304.
19. Fielding, P.E. and Fielding, C.J. (2002) Dynamics of lipoprotein transport in the human circulatory system, in Biochemistry of Lipids, Lipoproteins and Membranes (eds D.E. Vance and J.E. Vance), Elsevier, Amsterdam, pp. 527-52.
20. Merkel, M., Eckel, R.H. and Goldberg, I.J. (2002) Lipoprotein lipase: genetics, lipid uptake, and regulation. J Lipid Res, 43, 1997-2006.
21. Mead, J.R., Irvine, S.A. and Ramji, D.P. (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med, 80, 753-69.
22. Cooper, A.D. (1997) Hepatic uptake of chylomicron remnants. J Lipid Res, 38, 2173-92.
23. Mahley, R.W. and Rall, S.C. Jr. (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet, 1, 507-37.
24. Mahley, R.W. and Ji, Z.S. (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res, 40, 1-16.
25. Schneider, W.J. (2002) Lipoprotein receptors, in Biochemistry of Lipids, Lipoproteins and Membranes (ed. D.E. Vance), Elsevier, Amsterdam, pp. 553-72.
26. Packard, C.J. and Shepherd, J. (1997) Lipoprotein heterogeneity and apolipoprotein B metabolism. Arterioscler Thromb Vasc Biol, 17, 3542-56.
27. Brown, M.S. and Goldstein, J.L. (1986) A receptormediated pathway for cholesterol homeostasis. Science, 232, 34-47.
28. Horton, J.D., Goldstein, J.L. and Brown, M.S. (2002) SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 109, 1125-31.
29. Lewis, G.F. and Rader, D.J. (2005) New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res, 96, 1221-32.
30. Silver, D.L., Jiang, X.C., Arai, T., Bruce, C. and Tall, A.R. (2000) Receptors and lipid transfer proteins in HDL metabolism. Ann N Y Acad Sci, 902, 103-11.
31. Zannis, V.I., Chroni, A. and Krieger, M. (2006) Role of apoA-I, ABCA1, LCAT, and SR-BI in the biogenesis of HDL. J Mol Med, 84, 276-94.
32. Blanco-Vaca, F., Escola-Gil, J.C., Martin-Campos, J.M. and Julve, J. (2001) Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein. J Lipid Res, 42, 1727-39.
33. Timmins, J.M., Lee, J.Y., Boudyguina, E., Kluckman, K.D., Brunham, L.R., Mulya, A., Gebre, A.K., Coutinho, J.M., Colvin, P.L., Smith, T.L., Hayden, M.R., Maeda, N. and Parks, J.S. (2005) Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I. J Clin Invest, 115, 1333-42.
34. Kiss, R.S., McManus, D.C., Franklin, V., Tan, W.L., McKenzie, A., Chimini, G. and Marcel, Y.L. (2003) The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and-independent pathways. J Biol Chem, 278, 10119-27.
35. Webb, N.R., Cai, L., Ziemba, K.S., Yu, J., Kindy, M.S., van der Westhuyzen, D.R. and de Beer, F.C. (2002) The fate of HDL particles in vivo after SR-BI-mediated selective lipid uptake. J Lipid Res, 43, 1890-98.
36. Rye, K.A. and Barter, P.J. (2004) Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol, 24, 421-28.
37. Yancey, P.G., Bortnick, A.E., Kellner-Weibel, G., de la Llera-Moya, M., Phillips, M.C. and Rothblat, G.H. (2003) Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol, 23, 712-19.
38. Jonas, A. (2000) Lecithin cholesterol acyltransferase. Biochim Biophys Acta, 1529, 245-56.
39. Jiang, X.C. (2002) The effect of phospholipid transfer protein on lipoprotein metabolism and atherosclerosis. Front Biosci, 7, d1634-41.
40. Jiang, X.C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O.L. and Tall, A.R. (1999) Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest, 103, 907-14.
41. Rothblat, G.H., de la Llera-Moya, M., Atger, V., Kellne-Weibel, G., Williams, D.L. and Phillips, M.C. (1999) Cell cholesterol efflux: integration of new and old observations provides new insights. J Lipid Res, 40, 781-96.
42. Tall, A.R., Yvan-Charvet, L., Terasaka, N., Pagler, T. and Wang, N. (2008) HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. Cell Metab, 7, 365-75.
43. Renshaw, P.F., Janoff, A.S. and Miller, K.W. (1983) On the nature of dilute aqueous cholesterol suspensions. J Lipid Res, 24, 47-51.
44. Acton, S., Rigotti, A., Landschulz, K.T., Xu, S., Hobbs, H.H. and Krieger, M. (1996) Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science, 271, 518-20.
45. Silver, D.L. (2002) A Carboxyl-terminal PDZ-interacting domain of scavenger receptor B, type I is essential for cell surface expression in liver. J Biol Chem, 277, 34042-47.
46. Barter, P.J., Brewer, H.B. Jr., Chapman, M.J., Hennekens, C.H., Rader, D.J. and Tall, A.R. (2003) Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis. Arterioscler Thromb Vasc Biol, 23, 160-67.
47. Rye, K.A., Clay, M.A. and Barter, P.J. (1999) Remodelling of high density lipoproteins by plasma factors. Atherosclerosis, 145, 227-38.
48. Chiang, J.Y. (2004) Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J Hepatol, 40, 539-51.
49. Wang, D.Q., Cohen, D.E. and Carey, M.C. (2009) Biliary lipids and gallstone formation. J Lipid Res, 50, S406-11.
50. Oude Elferink, R.P., Paulusma, C.C. and Groen, A.K. (2006) Hepatocanalicular transport defects: pathophysiologic mechanisms of rare diseases. Gastroenterology, 130, 908-25.
51. Stieger, B., Meier, Y. and Meier, P.J. (2007) The bile salt export pump. Pflugers Arch, 453, 611-20.
52. Oude Elferink, R.P. and Paulusma, C.C. (2007) Function and pathophysiological importance of ABCB4 (MDR3P-glycoprotein). Pflugers Arch, 453, 601-10.
53. Hazard, S.E. and Patel, S.B. (2007) Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols. Pflugers Arch, 453, 745-52.
54. Carey, M.C. and Duane, W.C. (1994) Enterohepatic circulation, in The Liver: Biology and Pathobiology (eds I.M. Arias, J.L. Boyer, N. Fausto, W.B. Jakoby, D.A. Schachter and D.A. Shafritz), Raven Press, New York, pp. 719-67.
55. Kalaany, N.Y. and Mangelsdorf, D.J. (2006) LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu Rev Physiol, 68, 159-91.
56. Vlahcevic, Z.R., Pandak, W.M. and Stravitz, R.T. (1999) Regulation of bile acid biosynthesis. Gastroenterol Clin North Am, 28, 1-25.
57. Cohen, D.E., Kaler, E.W. and Carey, M.C. (1993) Cholesterol carriers in human bile: Are “Lamellae” involved? Hepatology, 18, 1522-31.
58. Cohen, D.E. (1996) Hepatocellular transport and secretion of biliary phospholipids. Semin Liver Dis, 16, 191-200.
59. Grundy, S.M. and Metzger, A.L. (1972) A physiological method for estimation of hepatic secretion of biliary lipids in man. Gastroenterology, 62, 1200-17.
60. Grundy, S.M. (1983) Absorption and metabolism of dietary cholesterol. Annu Rev Nutr, 3, 71-96.
61. Reuben, A., Maton, P.N., Murphy, G.M. and Dowling, R.H. (1985) Bile lipid secretion in obese and non-obese individuals with and without gallstones. Clin Sci, 69, 71-79.
62. Northfield, T.C. and Hofmann, A.F. (1975) Biliary lipid output during three meals and an overnight fast. I. Relationship to bile acid pool size and cholesterol saturation of bile in gallstone and control subjects. Gut, 16, 1-11.
63. Cohen, D.E. (2008) Balancing cholesterol synthesis and absorption in the gastrointestinal tract. J Clin Lipidol, 2, S1-S3.
64. Sehayek, E., Nath, C., Heinemann, T., McGee, M., Seidman, C.E., Samuel, P. and Breslow, J.L. (1998) U-shape relationship between change in dietary cholesterol absorption and plasma lipoprotein responsiveness and evidence for extreme interindividual variation in dietary cholesterol absorption in humans. J Lipid Res, 39, 2415-22.
65. Bosner, M.S., Lange, L.G., Stenson, W.F. and Ostlund, R.E. (1999) Percent cholesterol absorption in normal women and men quantified with dual stable isotopic tracers and negative ion mass spectrometry. J Lipid Res, 40, 302-8.
66. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA, 285, 2486-97.
67. Grundy, S.M., Cleeman, J.I., Merz, C.N., Brewer, H.B. Jr., Clark, L.T., Hunninghake, D.B., Pasternak, R.C., Smith, S.C. Jr. and Stone, N.J. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol, 44, 720-32.
68. Einarsson, K., Ericsson, S., Ewerth, S., Reihner, E., Rudling, M., Stahlberg, D. and Angelin, B. (1991) Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism. Eur J Clin Pharmacol, 40 (Suppl 1), S53-58.
69. Watanabe, M., Houten, S.M., Wang, L., Moschetta, A., Mangelsdorf, D.J., Heyman, R.A., Moore, D.D. and Auwerx, J. (2004) Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c. J Clin Invest, 113, 1408-18.
70. Turley, S.D. and Dietschy, J.M. (2003) The intestinal absorption of biliary and dietary cholesterol as a drug target for lowering the plasma cholesterol level. Prev Cardiol 6, 29-33, 64.
71. Armstrong, M.J. and Carey, M.C. (1987) Thermodynamic and molecular determinants of sterol solubilities in bile salt micelles. J Lipid Res, 28, 1144-55.
72. Davis, H.R. Jr., Zhu, L.J., Hoos, L.M., Tetzloff, G., Maguire, M., Liu, J., Yao, X., Iyer, S.P., Lam, M.H., Lund, E.G., Detmers, P.A., Graziano, M.P. and Altmann, S.W. (2004) Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem, 279, 33586-92.
73. Zandbergen, F. and Plutzky, J. (2007) PPARalpha in atherosclerosis and inflammation. Biochim Biophys Acta, 1771, 972-82.
74. Mandard, S., Muller, M. and Kersten, S. (2004) Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci, 61, 393-416.
75. Sacks, F.M. (2006) The apolipoprotein story. Atheroscler Suppl, 7, 23-27.
76. Aalto-Setala, K., Fisher, E.A., Chen, X., Chajek-Shaul, T., Hayek, T., Zechner, R., Walsh, A., Ramakrishnan, R., Ginsberg, H.N. and Breslow, J.L. (1992) Mechanism of hypertriglyceridemia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apo CIII and reduced apo E on the particles. J Clin Invest, 90, 1889-900.
77. Duval, C., Muller, M. and Kersten, S. (2007) PPAR alpha and dyslipidemia. Biochim Biophys Acta, 1771, 961-71.
78. Millar, J.S., Duffy, D., Gadi, R., Bloedon, L.T., Dunbar, R.L., Wolfe, M.L., Movva, R., Shah, A., Fuki, I.V., McCoy, M., Harris, C.J., Wang, M.D., Howey, D.C. and Rader, D.J. (2009) Potent and selective PPAR-{alpha} agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome. Arterioscler Thromb Vasc Biol, 29, 140-6.
79. Kamanna, V.S. and Kashyap, M.L. (2008) Mechanism of action of niacin. Am J Cardiol, 101, 20B-26B.
80. Tunaru, S., Kero, J., Schaub, A., Wufka, C., Blaukat, A., Pfeffer, K. and Offermanns, S. (2003) PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect. Nat Med, 9, 352-55.
81. Shepherd, J., Packard, C.J., Patsch, J.R., Gotto, A.M. Jr. and Taunton, O.D. (1979) Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. J Clin Invest, 63, 858-67.
82. Bays, H. (2006) Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids. Am J Cardiol, 98, 71i-76i.
83. Davidson, M.H. (2006) Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids. Am J Cardiol, 98, 27i-33i.
84. Scappa, M.C., Kanno, K. and Cohen, D.E. (2007) Lipoprotein metabolism, In: The Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd Edition (eds J. Rodés, J.P. Benhamou, M.A. Rizzetto, J. Reichen and A. Blei), Blackwell, Oxford.
85. Cohen, D.E. and Armstrong, E.J. (2007) Pharmacology of Cholesterol and Lipoprotein Metabolism, In: Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy (eds D.E. Golan, A.H. Tashjian, E.J. Armstrong, J.M. Galanter, A.W. Armstrong, R.A. Arnaout and H.S. Rose), 2nd edn, Lippincott, Williams and Wilkins, Philadelphia.